Prot#: CAGO178A2304: A 52-Wk, Rndmzd, Dbl-Blnd, Plcbo-Cntrlld, Mlt-Cntr, Prllel-Gr Stdy of the Lng-Trm Effccy, Tolrblty & Sfty of Agomelatine 25 & 50 mg in the Prvntn of Rlps of Major Depressive Disorder (MDD) Fllwng Opn-Lbl Trtmnt of 16-24 Wks.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/07 → 5/12/08

Funding

  • Novartis Pharmaceuticals Corporation (CAGO178A2304)